|
Australian company listings
Anandis Limited
Anadis Limited a global leader in the development and manufacturing of polyclonal antibody products, based on patented colostrum priming and hyper-immunisation technologies. The all-natural dairy-derived platform, has a regulatory classification as GRAS (Generally Regarded as Safe) when administered orally. Leveraging a technology platform that has been carefully developed over a decade, Anadis is addressing a broad range of indications in the infectious diseases, immune mediated diseases and oncology fields. Read more.
Apollo Cytokine Research Pty Ltd
Apollo Cytokine Research is an innovative biotechnology company that has made major breakthroughs in the areas of drug delivery and expression of proteins from human cells. Apollo's priority therapeutic candidates are: an oral form of insulin for diabetes; oral and topical forms of Apollo’s proprietary hcx™ TNF blocker molecule for rheumatoid arthritis; and a topical form of the same TNF blocker for psoriasis. Read more.
Apollo Life Sciences
Apollo Life Sciences is a biopharmaceutical company that creates, manufactures and markets next-generation therapeutics. Apollo Life Sciences' strategic goal is to create, manufacture and market therapeutic products that satisfy unmet patient needs, using its oral and transdermal delivery platforms in combination with its library of more natural human proteins. Read more.
Australian Proteome Analysis Facility (APAF)
APAF is Australia’s premier protein discovery research/service facility working to discover and purify novel biomarkers for human health and agricultural biotech applications. Read more.
Australian Tissue Engineering Centre
A leading provider of innovative tissue engineering solutions is emerging in the heart of Melbourne’s biotech hub. The Australian Tissue Engineering Centre is a collaborative facility that brings world-class stem cell, biomedical engineering and microsurgery research bodies together to drive the delivery of benefits from Australia’s world-class tissue engineering research. Read more.
Betachek - National Diagnostic Products Pty Ltd
National Diagnostic Products Pty Ltd (NDP) is a privately held Australian biotech company specialising in medical diagnostics. NDP is dedicated to providing innovative diagnostic products through a commitment to research and development. Read more.
Bioclone Australia Pty Limited
Bioclone is an Australian-based subsidiary of Hitachi Chemical Co., Ltd specialising in the design and manufacture (including contract services) of high quality immunodiagnostic products for medical and research laboratory markets. Bioclone was formed in 1981 to take advantage of Australian expertise in medical research and biotechnology. Read more.
bioMD Limited
bioMD Limited is an Australian biotechnology company committed to the development and commercialisation of the novel ADAPT® Advanced Tissue Process. This process is used in the treatment of animal tissues that are subsequently used as human bioimplants. The ADAPT® proprietary platform technology produces a sterile, biocompatible, regenerative and durable bioimplant. Read more.
BioPharmica Ltd
BioPharmica (ASX:BPH) develops biomedical research with universities and hospitals. Current projects include: molecular discovery systems, tumour suppressor gene/cancer biomarker, molecular diagnostic test for infectious diseases, nanoprobe, and a brain anesthesia response (BAR) monitor. Read more.
BSD Robotics
BSD Robotics is considered the world leader in the design, manufacture and supply of high technology laboratory instruments used in the initial processing of dried bio-samples, such as blood. The company’s robotic instruments are used in applications such as neonatal screening and in DNA-related fields such as forensics, animal/plant breeding, HIV testing, drug discovery and bone marrow transplant. Read more.
Chemical Analysis employs the most advanced analytical equipment for meeting project diversity and timelines. We provide assistance in managing products through various stages of the life cycle - Discovery, Preclinical, Clinical and Post-market under tight deadlines. Chemical Analysis is contracted by many leading Pharmaceutical, Biotechnology and Veterinary companies within the Asia-Pacific Region with a high incidence of return business, thus demonstrating the high Quality and Value of service Chemical Analysis provides. Read more.
CollTech Australia Ltd
OVICOLL® is a naturally sourced and highly purified collagen that is a key and distinctive requirement for multiple cosmetic, research and medical applications.
Read more.
Diabetes Vaccine Development Centre (DVDC) facilitates the development of immunotherapies to stop the development of type 1 diabetes. It is a joint initiative of the Australian Government’s National Health and Medical Research Council (NHMRC) and the New York based Juvenile Diabetes Research Foundation International (JDRF). Read more.
Epichem provides services in synthetic and medicinal chemistry to the drug discovery and pharmaceutical industries. Epichem has an extensive array of equipment including a full range of parallel synthesis equipment to produce analogue libraries. Its laboratories also have full height fumehoods for large laboratory scale synthesis up to 1kg. Read more.
FABLS is an international network of 430 people with expertise in biological and biomedical sciences, chemistry, physics, optoelectronics, and medical research. Based in Australia, its focus is on the development of precision instrumentation, reagents and software to expand the boundaries in cellular diagnostics and imaging, environmental monitoring and the treatment of disease. Read more.
Fermiscan is commercialising a new diagnostic test for the presence of breast cancer based on X-ray diffraction of scalp hair. Fermiscan’s technology is protected by granted patents in the US, Australia, New Zealand and the EU, with patents pending in other major countries. The test is suitable for women of any age, is safe and its accuracy has been demonstrated in blinded trials. Read more.
GleneaglesCRC is a premier CRO focused on operations in the Asian and Australasian region, specialised in phase 1 to phase 4 clinical trials services. With an unparalleled network of sites and investigators, as well as cutting edge technology and a world-class infrastructure to support your needs, GleneaglesCRC is well positioned to assist you in any stage of your clinical R&D efforts. Local expertise at global standards is what we offer. Read more.
Griffith University
Australia’s Griffith University, Queensland is a regional leader in biotechnology with the Eskitis Institute, Institute for Glycomics and Genomics Research Centre. These centres collaborate with key industry and public sector health partners to deliver research benefits to the community through outcomes such as novel therapies, diagnostics, and analytical services. Read more.
Living Cell Technologies (LCT) is developing a cell based therapy, for the treatment of type 1 diabetes. The Company's proprietary cell encapsulation technology allows DiabeCell ® to be implanted without the need for toxic anti-rejection drugs. Read more.
Macquarie Medical Services
Macquarie Medical Systems is active in research, design, manufacture and sale of biomedical monitoring equipment and other innovative products including high quality, durable ECG and patient monitoring units, dermatoscopy and skin imaging products, and eHealth solutions. Read more.
Marinova specialises in the extraction of fucoidans, sulphated polysaccharides found in marine macroalgae. The company has developed a library of fucoidan derivatives, and can isolate patentable fractions as active ingredients for pharmaceutical or medical device products. The company is currently developing fucoidan bioactives for wound healing, cardiovascular and antiviral applications. Fucoidans are a natural alternative to heparin with similar bioactivity profiles. Read more.
Maverick Biosciences Pty Ltd
Maverick Biosciences is an Australian-based processor and exporter of animal-derived biologicals for use by international manufacturers of human and veterinary pharmaceuticals and vaccines, media and diagnostics, neutriceuticals, and medical devices. Read more.
Medsaic
The platform technology owned by Medsaic is for the detailed characterisation of cellular proteins. It is based on the capture of metabolically active cells by microarrays of antibodies bound to nitrocellulose coated microscope slides (the Chip) and is called DotScan™. Read more.
Murdoch University is a Western Australian-based research intensive university with strong links to industry. Murdoch currently hosts, or is in partnership with over 50 research centers, building on its strengths in veterinary and biomedical sciences, agricultural biotechnology, environmental technology solutions and hydrometallurgy. Read more.
Nanotechnology Victoria Ltd (NanoVic) has developed a portfolio of bionanotechnology activities with considerable commercial potential, exploiting the advantages offered by nanotechnology for improved drug delivery, medical imaging and diagnostic systems. To facilitate commercialisation of these products, two vehicles have been established - Interstitial NanoSystems (Interstitial NS) and Quintain NanoSystems (Quintain NS). Read more.
Newcastle Innovation enables businesses to benefit from breakthrough research in areas such as health, biotechnology, mining, minerals processing and energy, conducted by the University of Newcastle. Read more.
NewSouth Innovations Pty Limited (NSi) is the technology transfer company of the University of New South Wales, with a business model clearly focused on intellectual property (IP) commercialisation via the protection of IP, the licensing of that technology, and capital raising through the formation of spin-off companies. Read more.
The New South Wales Clinical Trials Business Development Centre (the Centre) has recently been established to facilitate national and international companies, wanting to conduct trials in Australia, to access Sydney and regional NSW clinical trialists with world class expertise and the research excellence and infrastructure to translate discovery into products and services. Read more.Nucleus Network provides a broad range of expertise on clinical research and product development to the global pharmaceutical, biotechnology and medical device industries. Nucleus Network was conceived by clinicians and researchers to provide a framework for world-class clinical research services for the Australian and international biotech industry. Read more.
Optiscan Pty Ltd
Optiscan Imaging Limited (Optiscan) is an Australian company that has developed and patented miniaturised confocal microscopes, and is a global leader in the development and application of microscopic imaging technologies for the medical market. The Company is listed on the Australian Stock Exchange. Read more .
Orthocell Pty Ltd
Orthocell's core technology will deliver the first truly effective clinical cellular therapeutic regeneration solution for the treatment of rotator cuff failure within the shoulder joint and other tendonopathy related injuries. Read more .
Panbio Limited
Panbio Limited is an Australian-based international diagnostics company that develops, manufactures and markets innovative diagnostic tests to aid in the diagnosis of infectious disease. Read more.
Polartechnics Limited
Polartechnics is a listed Australian biotechnology company specialising in cancer detection and screening technologies for women's health and skin cancer. It holds a portfolio of global patents, and successfully completed CE certification/TGA registration for first generation award winning medical devices. Key products include Truscreen, for detecting cervical cancer, Solarscan, for detecting melanoma, and Mediscan, a digital imaging electronic health record with a highly flexible data set at the point of care. Read more.
Protech Research Pty Ltd
Protech researches and develops technology primarily for the food and food ingredient industries including for the ingredient protection during manufacture, enzyme extraction, flavour enhancement, salt control and drug delivery. Read more.
QRxPharma is a clinical-stage specialty pharmaceutical company with a core focus on the development and commercialisation of pain therapy products. The Company’s lead products comprise a patented combination of existing drugs, with a well defined path to regulatory approval and sales. QRxPharma’s lead drug compound, Q8003IR, is intended to begin Phase III clinical trials in 2007. The Company’s preclinical and clinical pipeline includes other technologies in the fields of neurodegenerative disease and venomics. Read more.
QUT is a top Australian university with global connections, a wide range of studies and applied research. QUT has a strong reputation for solving problems for industry and the community, and developing new products. QUT fosters a research environment that supports large-scale, outcome-based research endeavours through focus on areas of research expertise, and internal and external collaboration. Read more.
Seagull Technology's platform drug delivery device is designed for the non-invasive delivery of drugs by an innovative combination of nanotechnology and ultrasound. In its first application, it will facilitate a safer and more comfortable delivery of drugs to the back of the eye to manage diseases such as age-related macular degeneration. Currently needle injections are required every six to eight weeks to prevent blindness. Needle injection in the eye can result in retinal detachment and infection. Read more.
Selborne Biological Services is a leading supplier of specialized products of animal origin for the biotech, pharmaceutical, veterinary, and diagnostics industries. Selborne has been producing high quality biological products for more than 30 years. Its operations now span three continents, with offices in Australia, Europe, and North America. Selborne's principal manufacturing facilities are located in the rural community of Longford on the northern end of Tasmania, Australia's magnificent island state. Read more.
Southern Cross University has a focus on plant science developing value added products in agricultural and food biotechnology. Key technologies in high throughput genome and transcriptome analysis provide opportunities to develop genotypes with unique traits for food, industrial and bioenergy applications. Read more.
Special Phage Services Pty Ltd
SPS is a Sydney-based biopharmaceutical company set up to develop and commercialise bacteriophage therapy products. Read more.
Stirling Products Limited (Stirling) is an animal healthcare company. Stirling currently has two technology platforms. ProVale™ is a market introduced yeast beta Glucan which boosts the hosts immune system. R-salbutamol is a metabolic modifier that repartitions energy ('more muscle less fat'). Stirling's three market areas of interest are: companion animals – including obesity treatment and general health; treatment for respiratory disorders in horses; and growth agents in livestock. Read more.
Sypharma provides solutions to your contract manufacturing problems. Sypharma is one of the newest contract manufacturers of large and small volume parenterals, haemodialysis concentrates, and veterinary medicines in Australia. We provide aseptic and terminally sterilised injectables, biopharmaceutical formulation and processing, as well as a range of other capabilities, including in house chemistry and microbiology. Our dedicated team of professionals will put the GMP into your process. Read more.
TeleMedCare Pty Ltd was established to commercialise home telecare technologies developed by the Biomedical Systems Laboratory at the University of NSW in Australia. The TeleMedCare Service offers flexibility to health professionals to manage patients in their own home. For the first time, professionals are able to extend their formal standards of care, into the informal settings of the home. Read more.
The University of Queensland’s Institute for Molecular Bioscience, Queensland Brain Institute, Australian Institute for Biotechnology & Nanoengineering and Diamantina Institute for Cancer, Immunology & Metabolic Medicine hold nearly 1,000 researchers, and combine leading facilities with a culture of research excellence and technology transfer. Read more.
UniQuest Pty Limited at The University of Queensland UniQuest is widely recognized as one of Australia’s largest and most successful university commercialization groups. For almost 25 years UniQuest has been managing and commercializing an extensive intellectual property portfolio, including core technologies in vaccine development and diagnostic devices. Read more.
The University of Tasmania is the fourth oldest university in Australia. It is a research-led university, with a high standard of teaching and strong international focus. The School of Chemistry has a strong research focus in separation science, environmental, computational, natural products and synthetic chemistry. Read more.
The School of Pharmacy at the University of Tasmania has considerable expertise in the biotech area and undertakes consultancies and collaborative projects with industry over a diverse range of projects including natural product drug discovery and specialised bio-analytical applications. The University and its partners are actively seeking investors and industry partners for commercialisation of exciting products and technologies. Read more.
The University of Western Australia is recognised internationally as a Centre of Research Excellence. UWA is keen to explore opportunities for collaborative research as well as licensing and other commercialisation of its discoveries with interested biotech and pharmaceutical companies. Read more.
University of Wollongong
University of Wollongong is developing and commercialising early stage intellectual property in the Life science area. Initial focus is on drug reformulation for cancer treatment, cancer targeting biological, GAS vaccine candidates, real time radiation monitoring devices for Brachytherapy and novel nutraceuticals targeting appetite. Read more.
Vital Diagnostics
Vital Diagnostics are a company that manufactures and supports a diverse range of reagents and instrumentation for the diagnostic laboratory. The company based in Sydney, Australia has manufacturing facilities in Australia and the USA. Read more.
|
|
|